Half-year report · Q2
2112.TEDINET S100UNRS
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥31.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥546m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥901m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥901m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥26.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥26.2bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.3bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥13.8bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.4bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥13.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥12.5bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥434m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥372m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥227m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥76m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥38.53 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.95 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.01 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 53.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥67m |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥8m |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥39m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥62m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥62m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥701m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥838m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥799m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥39m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥186m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥14m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥16.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥62m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥2.1bn |
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥67m |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥8m |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥37m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥59m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥59m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥621m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥964m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥927m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥37m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥211m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥13m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥919m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥59m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 497
| Item | Context | Value | Unit |
|---|---|---|---|
| Current portion of long term loans payable | Prior1YearInstant | 2000000000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 1604000000 | JPY |
| Income taxes payable | Prior1YearInstant | 356000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 490000000 | JPY |
| Accrued consumption taxes | Prior1YearInstant | 178000000 | JPY |
| Accrued consumption taxes | CurrentQuarterInstant | 272000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 63000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 66000000 | JPY |
| Other cl | Prior1YearInstant | 1275000000 | JPY |
| Other cl | CurrentQuarterInstant | 906000000 | JPY |
| Current liabilities | Prior1YearInstant | 9313000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 7991000000 | JPY |
| Long term loans payable | Prior1YearInstant | 3873000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 3769000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 185000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 187000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 191000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 123000000 | JPY |
| Other ncl | Prior1YearInstant | 232000000 | JPY |
| Other ncl | CurrentQuarterInstant | 224000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 4482000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 4304000000 | JPY |
| Liabilities | Prior1YearInstant | 13796000000 | JPY |
| Liabilities | CurrentQuarterInstant | 12296000000 | JPY |
| Capital stock | Prior1YearInstant | 1750000000 | JPY |
| Capital stock | CurrentQuarterInstant | 1750000000 | JPY |
| Capital surplus | Prior1YearInstant | 241000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 241000000 | JPY |
| Retained earnings | Prior1YearInstant | 13773000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 14575000000 | JPY |
| Treasury stock | Prior1YearInstant | -2916000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -2890000000 | JPY |
| Shareholders equity | Prior1YearInstant | 12848000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 13675000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 799000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 663000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 0 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -14000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 63000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 59000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 862000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 708000000 | JPY |
| Net assets | Prior1YearInstant | 13711000000 | JPY |
| Net assets | CurrentQuarterInstant | 14384000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 27507000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 26680000000 | JPY |
| Net sales | Prior1YTDDuration | 15566000000 | JPY |
| Net sales | CurrentYTDDuration | 16162000000 | JPY |
| Cost of sales | Prior1YTDDuration | 13500000000 | JPY |
| Cost of sales | CurrentYTDDuration | 13106000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |